Skip to main content

Table 1 Baseline characteristics and perioperative demographics

From: Intravenous and subsequent long-term oral tranexamic acid in enhanced-recovery primary total knee arthroplasty without the application of a tourniquet: a randomized placebo-controlled trial

Variable Group A (N = 60) Group B (N = 58) P value
Patient characteristics
 Age (year)b 63.0 ± 13.9 64.1 ± 9.3 0.62
 Gender (male/female) a 15/45 11/47 0.43
 Height (m)b 1.5 ± 0.06 1.6 ± 0.07 0.07
 Weight (kg)b 60.9 ± 10.7 62.3 ± 10.4 0.46
 BMI (kg/m2)b 25.7 ± 5.0 25.5 ± 3.9 0.79
 ASA classificationb 2.1 ± 0.3 2.1 ± 0.4 0.53
 Operated side (L/R) a 26/34 31/27 0.27
 PBV (L)b 3.5 ± 0.4 3.6 ± 0.5 0.19
 Caprini scoresb 5.1 ± 2.5 5.6 ± 2.6 0.46
Preoperative laboratory values
 Hemoglobin (g/L)b 130.5 ± 13.7 128.3 ± 13.2 0.36
 Hematocrit (%)b 39.1 ± 3.7 38.7 ± 3.7 0.55
 Platelet count (× 109/L)b 182.7 ± 55.2 179.1 ± 45.5 0.73
 Albumin (g/L)b 42.0 ± 6.1 43.0 ± 3.2 0.28
 FDP (mg/L)b 3.1 ± 2.5 2.9 ± 2.4 0.70
 D-Dimer (mg/L)b 1.0 ± 1.4 1.2 ± 1.4 0.46
 PT (s)b 11.4 ± 0.7 11.3 ± 1.0 0.62
Surgical data
 Operative time (min)b 62.9 ± 13.1 63.6 ± 12.4 0.56
Preoperative knee function
 ROM (°)b 98.0 ± 22.4 96.6 ± 17.4 0.71
 KSS clinical scoreb 35.8 ± 14.4 36.2 ± 15.8 0.89
 KSS function scoreb 42.4 ± 11.6 41.2 ± 10.1 0.57
 Knee circumference (cm)b 41.1 ± 4.0 41.4 ± 3.5 0.58
 VAS pain scoreb 5.4 ± 1.4 5.8 ± 1.5 0.10
  1. aThe values are given as the number of patients
  2. bThe values are presented as the mean and the standard deviation